Influenza virus vaccine 2016-2017 Quadrivalent Nasal Spray
RxNorm 1801824

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1801824 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: influenza virus vaccine 2016-2017 Quadrivalent Nasal Spray.

The following semantic concepts and normalized strings are associated with this clinical entity:

SCD
Influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 mg/ML / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 mg/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 mg/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 mg/ML Nasal Spray
Primary clinical definition
AUI:8238994
PSN
Influenza virus vaccine 2016-2017 Quadrivalent Nasal Spray
AUI:8239004
SY
Influenza virus vaccine, live attenuated, 2016-2017 Quadrivalent Nasal Spray
AUI:8239003

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SCD

Semantic Clinical Drug (SCD):
Influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 mg/ML / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 mg/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 mg/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 mg/ML Nasal Spray
(Atom ID: 8238994)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
influenza A virus A/Bolivia/559/2013 (H1N1) antigen 50000000 MG/ML / influenza A virus A/New Caledonia/71/2014 (H3N2) antigen 50000000 MG/ML / influenza B virus B/Brisbane/60/2008 antigen 50000000 MG/ML / influenza B virus B/Phuket/3073/2013 antigen 50000000 MG/ML Nasal Spray
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1801824
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
8238994
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SCD
Semantic Clinical Drug (Ingredient + Strength + Dose Form)
Source Code
1801824
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN OBSOLETED
07/01/2020
Date the RxNorm atom became obsolete
RXTERM FORM
Spray
The RxTerm dose form name for this drug

PSN

Prescribable Name (PSN):
Influenza virus vaccine 2016-2017 Quadrivalent Nasal Spray
(Atom ID: 8239004)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
influenza virus vaccine 2016-2017 Quadrivalent Nasal Spray
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1801824
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
8239004
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PSN
Prescribable Name (Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept.)
Source Code
1801824
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

SY

Synonym (SY):
Influenza virus vaccine, live attenuated, 2016-2017 Quadrivalent Nasal Spray
(Atom ID: 8239003)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
influenza virus vaccine, live attenuated, 2016-2017 Quadrivalent Nasal Spray
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1801824
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
8239003
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1801824
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Patient Education

Flu Shot


Flu is a respiratory infection caused by a number of viruses. Most people with the flu get better on their own. But it can be serious. It can cause complications and sometimes even death. Getting the flu vaccine every year is the best way to lower your chance of getting the flu and spreading it to others.

The flu vaccine causes antibodies to develop in your body about two weeks after you get it. These antibodies provide protection against infection with the viruses that are in the vaccine.

There are different types of flu shots, including some especially for people 65 and older. Ask your health care provider which one is right for you.

Everyone 6 months of age and older should get a flu vaccine every season. People with egg allergies should check with their doctors before getting a vaccine. Other exceptions are people who have

Centers for Disease Control and Prevention


[Learn More]


* Please review the disclaimer below.